Cargando…

Mental health service users’ progression from illicit drug use to schizophrenia in New Zealand

BACKGROUND: Recently, publications have hypothesised that the demonstrated increase in the incidence of schizophrenia in New Zealand is a side effect of the increased strength of available cannabis derivatives over the last 25+ years and the much more recent increase in the population’s use of metha...

Descripción completa

Detalles Bibliográficos
Autores principales: Mellsop, Graham, Tapsell, Rees, Holmes, Pragya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738695/
https://www.ncbi.nlm.nih.gov/pubmed/31552389
http://dx.doi.org/10.1136/gpsych-2019-100088
_version_ 1783450858457923584
author Mellsop, Graham
Tapsell, Rees
Holmes, Pragya
author_facet Mellsop, Graham
Tapsell, Rees
Holmes, Pragya
author_sort Mellsop, Graham
collection PubMed
description BACKGROUND: Recently, publications have hypothesised that the demonstrated increase in the incidence of schizophrenia in New Zealand is a side effect of the increased strength of available cannabis derivatives over the last 25+ years and the much more recent increase in the population’s use of methamphetamine. AIM: To compare the rates of later schizophrenia between age-matched mental health service users with initial diagnoses as alcohol abusers or illicit drug users. METHOD: From the PRIMHD comprehensive national database, all users of the mental health services over a 5-year period who received an ICD-10 presenting diagnosis of alcohol or substance use/abuse were identified. For each person identified, the database was examined for the following 3 years to determine the numbers later diagnosed with schizophrenia. RESULTS: For the initial alcohol problem people in their twenties, 1.7% were diagnosed as suffering from schizophrenia in the subsequent 3 years. For the initial drug problem people, the rate was 10.9%. Within that drug-using population, the indigenous Maori developed schizophrenia at a higher rate than did the remainder of the population. CONCLUSION: These findings in New Zealand require further research into their generalisability, context and explanation.
format Online
Article
Text
id pubmed-6738695
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-67386952019-09-24 Mental health service users’ progression from illicit drug use to schizophrenia in New Zealand Mellsop, Graham Tapsell, Rees Holmes, Pragya Gen Psychiatr Original Research BACKGROUND: Recently, publications have hypothesised that the demonstrated increase in the incidence of schizophrenia in New Zealand is a side effect of the increased strength of available cannabis derivatives over the last 25+ years and the much more recent increase in the population’s use of methamphetamine. AIM: To compare the rates of later schizophrenia between age-matched mental health service users with initial diagnoses as alcohol abusers or illicit drug users. METHOD: From the PRIMHD comprehensive national database, all users of the mental health services over a 5-year period who received an ICD-10 presenting diagnosis of alcohol or substance use/abuse were identified. For each person identified, the database was examined for the following 3 years to determine the numbers later diagnosed with schizophrenia. RESULTS: For the initial alcohol problem people in their twenties, 1.7% were diagnosed as suffering from schizophrenia in the subsequent 3 years. For the initial drug problem people, the rate was 10.9%. Within that drug-using population, the indigenous Maori developed schizophrenia at a higher rate than did the remainder of the population. CONCLUSION: These findings in New Zealand require further research into their generalisability, context and explanation. BMJ Publishing Group 2019-09-05 /pmc/articles/PMC6738695/ /pubmed/31552389 http://dx.doi.org/10.1136/gpsych-2019-100088 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Original Research
Mellsop, Graham
Tapsell, Rees
Holmes, Pragya
Mental health service users’ progression from illicit drug use to schizophrenia in New Zealand
title Mental health service users’ progression from illicit drug use to schizophrenia in New Zealand
title_full Mental health service users’ progression from illicit drug use to schizophrenia in New Zealand
title_fullStr Mental health service users’ progression from illicit drug use to schizophrenia in New Zealand
title_full_unstemmed Mental health service users’ progression from illicit drug use to schizophrenia in New Zealand
title_short Mental health service users’ progression from illicit drug use to schizophrenia in New Zealand
title_sort mental health service users’ progression from illicit drug use to schizophrenia in new zealand
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738695/
https://www.ncbi.nlm.nih.gov/pubmed/31552389
http://dx.doi.org/10.1136/gpsych-2019-100088
work_keys_str_mv AT mellsopgraham mentalhealthserviceusersprogressionfromillicitdrugusetoschizophreniainnewzealand
AT tapsellrees mentalhealthserviceusersprogressionfromillicitdrugusetoschizophreniainnewzealand
AT holmespragya mentalhealthserviceusersprogressionfromillicitdrugusetoschizophreniainnewzealand